Matches in Wikidata for { <http://www.wikidata.org/entity/Q37486125> ?p ?o ?g. }
Showing items 1 to 85 of
85
with 100 items per page.
- Q37486125 description "1971年學術文章" @default.
- Q37486125 description "article científic" @default.
- Q37486125 description "article scientifique" @default.
- Q37486125 description "articolo scientifico" @default.
- Q37486125 description "artigo científico" @default.
- Q37486125 description "artículu científicu espublizáu en 1971" @default.
- Q37486125 description "bilimsel makale" @default.
- Q37486125 description "scientific article published on September 1971" @default.
- Q37486125 description "vedecký článok" @default.
- Q37486125 description "vetenskaplig artikel" @default.
- Q37486125 description "videnskabelig artikel" @default.
- Q37486125 description "vědecký článek" @default.
- Q37486125 description "wetenschappelijk artikel" @default.
- Q37486125 description "wissenschaftlicher Artikel" @default.
- Q37486125 description "наукова стаття, опублікована у вересні 1971" @default.
- Q37486125 description "научни чланак" @default.
- Q37486125 description "مقالة علمية نشرت في سبتمبر 1971" @default.
- Q37486125 name "Conditions leading to enhanced response to glucagon, epinephrine, or prostaglandins by adenylate cyclase of normal and malignant cultured cells" @default.
- Q37486125 name "Conditions leading to enhanced response to glucagon, epinephrine, or prostaglandins by adenylate cyclase of normal and malignant cultured cells" @default.
- Q37486125 name "Conditions leading to enhanced response to glucagon, epinephrine, or prostaglandins by adenylate cyclase of normal and malignant cultured cells" @default.
- Q37486125 type Item @default.
- Q37486125 label "Conditions leading to enhanced response to glucagon, epinephrine, or prostaglandins by adenylate cyclase of normal and malignant cultured cells" @default.
- Q37486125 label "Conditions leading to enhanced response to glucagon, epinephrine, or prostaglandins by adenylate cyclase of normal and malignant cultured cells" @default.
- Q37486125 label "Conditions leading to enhanced response to glucagon, epinephrine, or prostaglandins by adenylate cyclase of normal and malignant cultured cells" @default.
- Q37486125 prefLabel "Conditions leading to enhanced response to glucagon, epinephrine, or prostaglandins by adenylate cyclase of normal and malignant cultured cells" @default.
- Q37486125 prefLabel "Conditions leading to enhanced response to glucagon, epinephrine, or prostaglandins by adenylate cyclase of normal and malignant cultured cells" @default.
- Q37486125 prefLabel "Conditions leading to enhanced response to glucagon, epinephrine, or prostaglandins by adenylate cyclase of normal and malignant cultured cells" @default.
- Q37486125 P1104 Q37486125-90C5224A-D7F6-4AD6-8060-9199C36CEAD0 @default.
- Q37486125 P1433 Q37486125-1B8F79DE-790E-48B7-8E53-74E1D192B6CB @default.
- Q37486125 P1476 Q37486125-709593DB-B207-42A8-B9DD-7EA9AE68760A @default.
- Q37486125 P2093 Q37486125-90467D9B-B92A-4126-8C05-93187376E970 @default.
- Q37486125 P2860 Q37486125-11579167-5F8E-4D17-8A9E-BE0C9A6741EB @default.
- Q37486125 P2860 Q37486125-3B58EA73-E9AF-4631-B040-224F93D73C1A @default.
- Q37486125 P2860 Q37486125-53543C56-A1AD-41A6-8EAC-7975CF8AB614 @default.
- Q37486125 P2860 Q37486125-6EEEA0DF-ED87-4D9C-97FB-15B8A19B7FEF @default.
- Q37486125 P2860 Q37486125-748EF4A3-49FF-438C-BD53-CE03FA584963 @default.
- Q37486125 P2860 Q37486125-9E9A549B-8787-45AB-9DB1-8B248101650A @default.
- Q37486125 P2860 Q37486125-C43A189B-BDAC-45F2-91AF-88DF0E445099 @default.
- Q37486125 P2860 Q37486125-D30EE4DC-3F8C-439A-A160-43B4BEDB293B @default.
- Q37486125 P2860 Q37486125-DE8DA0A0-0F1C-432A-AA6D-E8ADB60A4B7B @default.
- Q37486125 P2860 Q37486125-EFE4F8CA-AF2E-4803-BA15-7648B9A789EB @default.
- Q37486125 P2860 Q37486125-F43AA126-B598-44EA-8580-1FB830060D8B @default.
- Q37486125 P304 Q37486125-569606F1-1CFF-406F-B9BF-45BD2A54CE37 @default.
- Q37486125 P31 Q37486125-1517EB47-8B5E-4FFB-8CCE-3D30DF49FEB9 @default.
- Q37486125 P356 Q37486125-E421D0FC-B4E2-4E7E-83B4-60A7A118A044 @default.
- Q37486125 P407 Q37486125-1293D92F-D296-4C12-900D-33B251ADDB51 @default.
- Q37486125 P433 Q37486125-31B86D36-64C7-47A5-83EC-79D10ABB9577 @default.
- Q37486125 P478 Q37486125-27D25DF2-157D-402D-82A9-FBB6D9DDBA84 @default.
- Q37486125 P577 Q37486125-AC62F2F0-3907-4760-9C5D-015A26175FE2 @default.
- Q37486125 P5875 Q37486125-73A831F0-846E-48F5-9E70-CE3A9D875EC2 @default.
- Q37486125 P698 Q37486125-6A9EBB87-4614-4F68-ABC2-245E06757D86 @default.
- Q37486125 P819 Q37486125-FED9A08B-DD74-4372-993B-2F76D8235FF4 @default.
- Q37486125 P921 Q37486125-538F7DAE-8D98-4412-9B84-82D86809BD03 @default.
- Q37486125 P921 Q37486125-971843EF-42B6-438C-8518-9A4C15998290 @default.
- Q37486125 P932 Q37486125-DFA343A8-2377-4E9E-AFF5-4C2FA52958AE @default.
- Q37486125 P356 PNAS.68.9.2127 @default.
- Q37486125 P698 4332246 @default.
- Q37486125 P1104 "+4" @default.
- Q37486125 P1433 Q1146531 @default.
- Q37486125 P1476 "Conditions leading to enhanced response to glucagon, epinephrine, or prostaglandins by adenylate cyclase of normal and malignant cultured cells" @default.
- Q37486125 P2093 "Makman MH" @default.
- Q37486125 P2860 Q36263015 @default.
- Q37486125 P2860 Q36448012 @default.
- Q37486125 P2860 Q37468604 @default.
- Q37486125 P2860 Q37469391 @default.
- Q37486125 P2860 Q37474439 @default.
- Q37486125 P2860 Q39605640 @default.
- Q37486125 P2860 Q44241429 @default.
- Q37486125 P2860 Q44714462 @default.
- Q37486125 P2860 Q68617579 @default.
- Q37486125 P2860 Q68730841 @default.
- Q37486125 P2860 Q71762849 @default.
- Q37486125 P304 "2127-2130" @default.
- Q37486125 P31 Q13442814 @default.
- Q37486125 P356 "10.1073/PNAS.68.9.2127" @default.
- Q37486125 P407 Q1860 @default.
- Q37486125 P433 "9" @default.
- Q37486125 P478 "68" @default.
- Q37486125 P577 "1971-09-01T00:00:00Z" @default.
- Q37486125 P5875 "18834174" @default.
- Q37486125 P698 "4332246" @default.
- Q37486125 P819 "1971PNAS...68.2127M" @default.
- Q37486125 P921 Q28163586 @default.
- Q37486125 P921 Q28163629 @default.
- Q37486125 P932 "389367" @default.